Ankita Patel's Profile

Role	Title	Level	Year	L/R
🐬	ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor C. Coffin, Ankita Patel, S. Perkins, K. Elenitoba-Johnson, E. Perlman, C. Griffin	9	2001	9 🐬
🐜	Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses. 7 auth. Akihiro Otsuki, Ankita Patel, K. Kasai, Masataka Suzuki, K. Kurozumi, E. Antonio Chiocca, ... Y. Saeki	7	2008	7 🐜
🐜	Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related Pathway* 10 auth. R. Rosato, S. Kolla, Stefanie K. Hock, Jorge A. Almenara, Ankita Patel, S. Amin, ... P. Atadja, P. Fisher, P. Dent, S. Grant	6	2010	6 🐜
🐜	DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells 10 auth. J. Tuomela, J. Sandholm, M. Kaakinen, Ankita Patel, J. Kauppila, J. Ilvesaro, ... Dongquan Chen, K. Harris, D. Graves, K. Selander	5	2013	5 🐜
🐜	Engineered DNA ligases with improved activities in vitro. 10 auth. Robert H. Wilson, S. Morton, Heather Deiderick, M. Gerth, H. A. Paul, Ilana Gerber, ... Ankita Patel, A. Ellington, S. Hunicke-Smith, W. Patrick	4	2013	4 🐜
🐜	Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses. 7 auth. Akihiro Otsuki, Ankita Patel, K. Kasai, Masataka Suzuki, K. Kurozumi, E. Chiocca, ... Y. Saeki	4	2008	4 🐜
🐬	Potential Advantages of Bone Marrow Sparing IMRT in Cancer Cervix: A Dosimetric Evaluation N. Gupta, C. Prakash, Kalpak Chakrabarty, U. Giri, Ankita Patel, S. Choudhary	2	2019	2 🐬
🐜	Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies—a Retrospective Bi-institutional Study 8 auth. S. Mehta, P. Kammar, Ankita Patel, G. Goswami, S. Shaikh, V. Sukumar, ... Esha Trivedi, A. Bhatt	2	2022	2 🐜
🐬	A Review on Azelaic Acid Emulgel for Acne and Hyperpigmentation Hemangini Amrutbhai Halpati, Ankita Patel, Sachin B. Narkhede	1	2019	1 🐬